Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale N Gerding

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
Journal of Clinical Microbiology|March 11, 2011
Comparison of strain typing results for Clostridium difficile isolates from North AmericaFred C Tenover, Thomas Akerlund, Dale N Gerding, et al.
Infection Control and Hospital Epidemiology|February 8, 2013
Effectiveness of hand hygiene for removal of Clostridium difficile spores from handsSarah L Edmonds, Carrie Zapka, Douglas Kasper, et al.
Infection Control and Hospital Epidemiology|June 6, 2015
Clostridium difficile Infection Among Veterans Health Administration PatientsYinong Young-Xu, Jennifer L Kuntz, Dale N Gerding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trialsStuart Johnson, Thomas J Louie, Dale N Gerding, et al.
Clinical Trials (London, England)|June 22, 2021
Microbiota or placebo after antimicrobial therapy for recurrent <i>Clostridioides difficile</i> at home: A clinical trial with novel home-based enrollmentDimitri M Drekonja, Aasma Shaukat, Jane H Zhang, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Infection Control and Hospital Epidemiology|November 28, 2002
Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospitalJoseph J Pulvirenti, Dale N Gerding, Catherine Nathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
Vaccine|November 28, 2009
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)Brett A Leav, Barbra Blair, Mark Leney, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Journal of Clinical Microbiology|March 11, 2011
Comparison of strain typing results for Clostridium difficile isolates from North AmericaFred C Tenover, Thomas Akerlund, Dale N Gerding, et al.
Infection Control and Hospital Epidemiology|February 8, 2013
Effectiveness of hand hygiene for removal of Clostridium difficile spores from handsSarah L Edmonds, Carrie Zapka, Douglas Kasper, et al.
Infection Control and Hospital Epidemiology|June 6, 2015
Clostridium difficile Infection Among Veterans Health Administration PatientsYinong Young-Xu, Jennifer L Kuntz, Dale N Gerding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trialsStuart Johnson, Thomas J Louie, Dale N Gerding, et al.
Clinical Trials (London, England)|June 22, 2021
Microbiota or placebo after antimicrobial therapy for recurrent <i>Clostridioides difficile</i> at home: A clinical trial with novel home-based enrollmentDimitri M Drekonja, Aasma Shaukat, Jane H Zhang, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Infection Control and Hospital Epidemiology|November 28, 2002
Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospitalJoseph J Pulvirenti, Dale N Gerding, Catherine Nathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
Vaccine|November 28, 2009
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)Brett A Leav, Barbra Blair, Mark Leney, et al.
Pageof 20